J Am Coll Cardiol,1998,31:1252-1257. 9 Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in man with hypercholesterolemia. N Engl J Med,1995，333:1301-1307.
10 Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high density lipoprotein cholesterol level: a meta-analysis of population based prospective studies. J Cardiovase Risk,1996，3:213-229.
11 Ericsson CG, Hamsten A, Nilsson J, et al. An angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Lancet,1996,347:849-853.
12 Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on
coronary heart disease risk in the Helsinki Heart Study: implications for treatment. Circulation,1992,70:733-737. 13 Mussoni L, Mannucci L, Sirtori M, et al. Hyperglyceridemia and regulation of fibrinolytic activity.Arterioscle Thromb,1992,12:19-25.
14 冯宁，冯宗忱.小、密低密度脂蛋白与冠心病.中华心血管病杂志，1997,25:237-239.
15 Frick MH, Syvanne M, Nieminen MS, et al. Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Circulation,1997，96:2137-2143.
16 Patch JR, Miesenbock G, Hopferwieser T, et al. Relation of triglyceride metabolism and coronary heart disease: studies in a postprandial state. Arterioscler Thromb,1992,12:1336-1345.
17 Torvall P, Bavenholm P, Landou C, et al. Relationship of angiographically defined coronary artery disease to plasma levels and composition of apolipoprotein B-containing lipoproteins in patients with myocardial infarction at young age. Circulation,1993,88:2180-2189.
18 Phillips NR, Waters D, Havel RJ. Plasma lipoproteins and progression of coronary artery disease evaluated by angi
上一页 [1] [2] [3] [4] [5] [6] 下一页
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文